D-0274-2024 Class II Terminated
FDA drug recall D-0274-2024 was initiated by Lupin Pharmaceuticals Inc. on Jan 3, 2024 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications The recall status is terminated (terminated Dec 27, 2024). Affected quantity: 4,608 Bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- Feb 7, 2024
- Initiation Date
- Jan 3, 2024
- Termination Date
- Dec 27, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4,608 Bottles
Product Description
Cefixime for Oral Suspension 100mg/5mL, 50 mL bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, Manufactured by:Lupin Limited, Mandideep 462 046 INDIA, NDC 68180-405-01
Reason for Recall
Failed Impurities/Degradation Specifications
Distribution Pattern
Nationwide in the USA
Code Information
Lot #: F304833, Exp 06/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0274-2024
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 24, 2026